Necessity is the mother of invention. In the pharmaceutical industry “necessity” might be characterized as patent expiration, regulatory and product development constraints, heightened competition, and the ongoing battle with patient compliance. Invention, therefore, lies in overcoming these hurdles. One way companies can achieve their goals is through innovative drug delivery techniques.
According to experts, emerging areas of drug delivery that have created a lot of buzz and offer real promise include nanotechnology-derived breakthroughs, such as nanosuspension technologies and nanoparticle oral formulations, and microelectronics…
Drivers of Innovation in Drug Delivery
Key Trends in Drug Delivery
Experts on this Topic
Troy Harmon. VP, Business Development, Eurand, Dayton, Ohio; Eurand is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products using its proprietary drug formulation technologies. For more information, visit eurand.com.
Bill Lambert, Ph.D. Senior VP, Pharmaceutical Development, Pacira Pharmaceuticals Inc., San Diego; Pacira is a pharmaceutical company with a primary focus on formulating, developing, and manufacturing controlled-release injectable products. For more information, visit pacira.com.
Karen L. Moynihan, Ph.D. Associate Professor, the Keck Graduate Institute (KGI), Claremont, Calif.; KGI is a graduate institution devoted solely to bioscience education and discovery. For more information, visit kgi.edu.
Robert W. Naismith, Ph.D. Chairman and CEO, Life Science Analytics Inc. (LSA), Scranton, Pa.; LSA is a biomedical data company that provides comprehensive pipeline and financial information on more than 10,000 biomedical companies worldwide. For more information, visit lifescienceanalytics.com.
Steven C. Quay, M.D., Ph.D. Chairman, President, and CEO, Nastech Pharmaceutical Company Inc., Bothell, Wash.; Nastech develops drug delivery technologies that focus on the regulation and manipulation of tight junction biology. For more information, visit nastech.com.
Graham Reynolds. VP, Safety and Administration Systems, West Pharmaceutical Services, Lionville, Pa.; West develops delivery systems that enhance the administration of pharmaceuticals. For more information, visit westpharma.com.
Eric Tomlinson, D.Sc., Ph.D. President and CEO, Altea Therapeutics, Atlanta; Altea Therapeutics is a private specialty pharmaceutical company developing and commercializing pharmaceutical products based on a new class of transdermal patches. For more information, visit alteatherapeutics.com.